{"Q": 1, "answer": "no", "rationale": "The segment describes funding and vaccine development, but does not use an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_14472", "batch_size": 200, "batch_pos": 81, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment describes vaccine development factually, without high-potency language.", "method": "llm_batch", "batch_id": "batch_2_8168", "batch_size": 200, "batch_pos": 21, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "This describes future action ('will be used'), not realised impact.", "method": "llm_batch", "batch_id": "batch_3_15012", "batch_size": 200, "batch_pos": 167, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment contains no question.", "method": "llm_batch", "batch_id": "batch_4_16792", "batch_size": 200, "batch_pos": 151, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports funding use but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17848", "batch_size": 200, "batch_pos": 147, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_15492", "batch_size": 200, "batch_pos": 102, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_15604", "batch_size": 200, "batch_pos": 87, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment describes 'Funds... will be used to complete late-stage development and testing', capability/preparedness.", "method": "llm_batch", "batch_id": "batch_8_16668", "batch_size": 200, "batch_pos": 119, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
